Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only

Journal of Surgical Oncology

Volumn 93, Issue 7, 2006, Pages 559-563

  Dillon, Mary F ^a,b   McDermott, Enda W ^a   Quinn, Cecily M ^a,c   O'Doherty, Ann ^a,c   O'Higgins, Niall ^a   Hill, Arnold D K ^a,b,c  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c BreastCheck   (Ireland)

Author keywords

Biopsy; Breast neoplasms; Carcinoma; Intraductal; Noninfiltrating

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CANCER; CANCER INVASION; CANCER SIZE; CARCINOMA IN SITU; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; STEREOTAXIC SURGERY;

BIOPSY; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CALCINOSIS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; SENTINEL LYMPH NODE BIOPSY; ULTRASONOGRAPHY, MAMMARY;

EID: 33744460728     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20445     Document Type: Article

References (24)

1. Wahedna Y, Evans AJ, Pinder SE, et al.: Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus. Eur J Can 2001;37:459-462.
2. Renshaw AA: Predicting invasion in the excision specimen from core needle biopsy specimens with only ductal carcinoma in situ. Arch Pathol Lab Med 2002;126:39-41.
3. Jackman RJ, Burbank F, Parker SH, et al.: Stereotactic breast biopsy of non palpable lesions: Determinants of ductal carcinoma in situ underestimation rates. Radiol 2001;218:497-502.
4. Lagios MD, Westdahl PR, Margolin FR, et al.: Duct carcinoma in situ. Relationship of extent of non-invasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short term treatment failures. Cancer 1982;50:1309-1314.
5. Lee CH, Carter D, Philpotts LE, et al.: Ductal Carcinoma in situ diagnosed with stereotactic core needle biopsy. Can invasion be predicted? Radiology 2000;217:466-470.
6. Bonnet M, Wallis T, Rossmann M, et al.: Histological and radiological analysis of ductal carcinoma in situ diagnosed stereotactic incisional core breast biopsy. Mod Pathol 2002;15:95-101.
7. Hoorntje LE, Schipper ME, Peeters PH, et al.: The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma in situ: Causes of ductal carcinoma in situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol 2003;10;748-753.
8. Mendez I, Andreu FJ, Saez E, et al.: Ductal carcinoma in situ and atypical ductal hyperplasia of the breast diagnosed at stereotactic core biopsy. Breast J 2001;7:14-18.
9. Yen TW, Hunt KK, Ross MI, et al.: Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005;200:516-526.
10. Mittendorf ME, Arciero CA, Gutchell V, et al.: Core biopsy diagnosis of ductal carcinoma in situ: An indication for sentinel lymph node biopsy. Curr Surg 2005;62:253-257.
11. Zavagno G, Carcoforo P, Marconato R, et al.: Role of axillary sentinel node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer 2005;5:28.
12. Klauber-Demore N, Tan LK, Liberman L, et al.: Sentinel lymph node biopsy: Is it indicated in patients with high risk ductal carcinoma-in-situ and ductal carcinoma in situ with microinvasion? Ann Surg Oncol 2000;7:636-642.
13. Intra M, Veronesi P, Mazzarol G, et al.: Axillary sentinel node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003;138:309-313.
14. Bagnell MJ, Evans AJ, Wilson AR, et al.: Predicting invasion in mammographically detected microcalcification. Clin Radiol 2001;56:828-832.
15. Sener SF, Candela FC, Paige ML, et al.: Limitations of mammography in the identification of non infiltrating carcinoma of the breast. Surg Gyn & Obst 1988;167:135-140.
16. Gajdos C, Tartter PI, Bleiweiss IJ, et al.: Mammographic appearance of nonpalpable breast cancer reflects pathological characteristics. Ann Surg 2002;235:246-251.
17. King TA, Farr GH Jr, Cederbom GJ. et al.: A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ. Am Surg 2001;67:907-912.
18. Parker SH, Burbank F, Jackman RJ, et al.: Percutaneous large core breast biopsy. A multi-institutional study. Radiology 1994;193:359-364.
19. Parker SH, Jobe WE, Dennis MA, et al.: US-guided automated large-core breast biopsy. Radiology 1993;187:507-511.
20. Liberman L, Feng TL, Dershaw DD: US-guided core breast biopsy: Use and cost effectiveness. Radiology 1998;208:717-723.
21. Yeow KM, Lo YF, Wang CS: Ultrasound-guided core needle biopsy as an initial diagnostic test for palpable breast masses. J Vasc Interv Radiol 2001;12:1313-1317.
22. Smith DN, Rosenfield Darling ML, Meyer JE, et al.: The utility of ultrasonographically guided large-core needle biopsy. J Ultrasound Med 2001;20:43-49.
23. Dillon MF, Hill AD, Quinn CM, et al.: The accuracy of ultrasound, stereotactic and clinical core biopsies in the diagnosis of breast cancer, with an analysis of false negative cases. Ann Surg 2005;242:701-707.
24. Kinkel K, Gilles R, Feger C, et al.: Focal areas of increased opacity in ductal carcinoma in situ of the comedo type: Mammographic-pathologic correlation. Radiology 1994;192:443-446.